Aymelt Itzen

Find an error

Name:
Organization: Technische Universit?t München , Germany
Department: Chemistry Department
Title: Professor(PhD)
Co-reporter:Aymelt Itzen
BIOspektrum 2016 Volume 22( Issue 4) pp:359-361
Publication Date(Web):2016 June
DOI:10.1007/s12268-016-0697-9
Bacterial pathogens have evolved with enzyme activities that may hijack intracellular signaling of mammalian cells to establish an infection. Of particular interest is a novel posttranslational modification referred to as adenylylation: An adenosine monophosphate group is covalently transferred to a mammalian target protein. Here, I discuss the consequences of adenylylation and its related modifications by Fic enzymes. Also, I comment on potential applications for protein labeling.
Co-reporter:Christian Hedberg and Aymelt Itzen
ACS Chemical Biology 2015 Volume 10(Issue 1) pp:12
Publication Date(Web):December 8, 2014
DOI:10.1021/cb500854e
In the cell, proteins are frequently modified covalently at specific amino acids with post-translational modifications, leading to a diversification of protein functions and activities. Since the introduction of high-resolution mass spectrometry, new post-translational modifications are constantly being discovered. One particular modification is the adenylylation of mammalian proteins. In adenylylation, adenosine triphosphate (ATP) is utilized to attach an adenosine monophosphate at protein threonine or tyrosine residues via a phosphodiester linkage. Adenylylation is particularly interesting in the context of infections by bacterial pathogens during which mammalian proteins are manipulated through AMP attachment via secreted bacterial factors. In this review, we summarize the role and regulation of enzymatic adenylylation and the mechanisms of catalysis. We also refer to recent methods for the detection of adenylylated proteins by modification-specific antibodies, ATP analogues equipped with chemical handles, and mass spectrometry approaches. Additionally, we review screening approaches for inhibiting adenylylation and briefly discuss related modifications such as phosphocholination and phosphorylation.
Co-reporter:M.Sc. Katharina Heller;M.Sc. Philipp Ochtrop;M.Sc. Michael F. Albers;Florian B. Zauner;Dr. Aymelt Itzen;Dr. Christian Hedberg
Angewandte Chemie International Edition 2015 Volume 54( Issue 35) pp:10327-10330
Publication Date(Web):
DOI:10.1002/anie.201502618

Abstract

We present a new protein labeling method based on the covalent enzymatic phosphocholination of a specific octapeptide amino acid sequence in intact proteins. The bacterial enzyme AnkX from Legionella pneumophila has been established to transfer functional phosphocholine moieties from synthetically produced CDP-choline derivatives to N-termini, C-termini, and internal loop regions in proteins of interest. Furthermore, the covalent modification can be hydrolytically removed by the action of the Legionella enzyme Lem3. Only a short peptide sequence (eight amino acids) is required for efficient protein labeling and a small linker group (PEG-phosphocholine) is introduced to attach the conjugated cargo.

Co-reporter:M.Sc. Katharina Heller;M.Sc. Philipp Ochtrop;M.Sc. Michael F. Albers;Florian B. Zauner;Dr. Aymelt Itzen;Dr. Christian Hedberg
Angewandte Chemie 2015 Volume 127( Issue 35) pp:10467-10471
Publication Date(Web):
DOI:10.1002/ange.201502618

Abstract

Wir präsentieren eine neue Methode zur Proteinmarkierung, die auf der kovalenten enzymatischen Phosphocholinierung einer spezifischen Octapeptidsequenz intakter Proteine beruht. Das Enzym AnkX aus Legionellen wurde etabliert, um funktionalisierte Phosphocholingruppen aus synthetischen CDP-Cholin-Derivaten auf N- und C-Termini, sowie interne Schleifenregionen zu übertragen. Zudem kann die kovalente Modifikation durch das Legionellen-Enzym Lem3 hydrolytisch entfernt werden. Lediglich eine 8 Aminosäuren kurze Peptidsequenz und eine kleine Verbindungsgruppe (PEG-Phosphocholin) sind für die effiziente Proteinmarkierung erforderlich.

Co-reporter:Dr. Matthias P. Müller;Michael F. Albers; Dr. Aymelt Itzen;Dr. Christian Hedberg
ChemBioChem 2014 Volume 15( Issue 1) pp:19-26
Publication Date(Web):
DOI:10.1002/cbic.201300508
Co-reporter:Emerich Mihai Gazdag, Stefan Schöbel, Alexander V. Shkumatov, Roger S. Goody, Aymelt Itzen
Journal of Structural Biology (April 2014) Volume 186(Issue 1) pp:188-194
Publication Date(Web):1 April 2014
DOI:10.1016/j.jsb.2014.02.003
The Gram-negative bacterium Legionella pneumophila is the causative agent of Legionnaires’ disease. During infection of eukaryotic cells, the bacterium releases about 300 different bacterial effector molecules that aid in the establishment of the Legionella-containing vacuole (LCV) among which SidC is one of these secreted proteins. However, apart from membrane lipid binding the function of SidC remains elusive. In order to characterize SidC further, we have determined the crystal structure of the N-terminal domain of SidC (amino acids 1–609, referred to as SidC-N) at 2.4 Å resolution. SidC-N reveals a novel fold in which 4 potential subdomains (A–D) are arranged in a crescent-like structure. None of these subdomains currently has any known structural homologues, raising the question of how this fold has evolved. These domains are highly interconnected, with a low degree of flexibility towards each other. Due to the extended arrangement of the subdomains, SidC-N may contain multiple binding sites for potential interaction partners.
Carbamic acid, [2-(2-iodoethoxy)ethyl]-, 1,1-dimethylethyl ester
1-Naphthalenesulfonamide,5-(dimethylamino)-N-[6-[(2,5-dioxo-1-pyrrolidinyl)oxy]-6-oxohexyl]-
Acetic acid, 2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]-
5,8,11-Trioxa-2-azatridecanoicacid, 13-hydroxy-, 1,1-dimethylethyl ester
6-Carboxyfluorescein N-succinimidyl ester
Ethanol, 2-[2-[2-(2-azidoethoxy)ethoxy]ethoxy]-
Ethanol, 2-[2-(2-azidoethoxy)ethoxy]-
Ethanol, 2-[2-(2-hydroxyethoxy)ethoxy]-, 1-(4-methylbenzenesulfonate)